CORE LABORATORIES INC. 2024-2025 Proxy Voting Records

Description as filed by funds: To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2028 and until their successors shall have been duly elected and qualified: Martha Z. Carnes

CORE LABORATORIES INC.’s own tally for this item (“Elect Director: Martha Z. Carnes”): 37,510,862 for, 2,818,729 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 70 asset managers below reported 20,465,589 for, 287,144 withheld, 2 abstained.

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

Description as filed by funds: To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2028 and until their successors shall have been duly elected and qualified: Katherine Murray

CORE LABORATORIES INC.’s own tally for this item (“Elect Director: Katherine Murray”): 39,747,197 for, 582,394 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 70 asset managers below reported 20,698,543 for, 54,191 withheld, 0 abstained.

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

Description as filed by funds: To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2028 and until their successors shall have been duly elected and qualified: Rob Martinovich

CORE LABORATORIES INC.’s own tally for this item (“Elect Director: Rob Martinovich”): 38,894,796 for, 1,434,795 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 70 asset managers below reported 20,750,546 for, 2,189 withheld, 0 abstained.

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis ("CD&A"), and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables.

CORE LABORATORIES INC.’s own tally for this item (“3. Approving the Compensation of the Company's Named Executive Officers: An advisory vote on the compensation of the Company's named executive officers”): 38,010,404 for, 2,292,675 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Approving the Compensation of the Company's Named Executive Officers : An advisory vote on the compensation of the Company's named executive officers was approved as follows:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 68 managers: 19,890,883 for, 860,622 against, 1,230 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 210 managers: 19,481,660 for, 1,361,568 against, 1,820 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the year ending December 31, 2025; and

CORE LABORATORIES INC.’s own tally for this item (“2. Appointment of KPMG as Independent Registered Public Accountant: The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, 2025”): 41,812,461 for, 685,311 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, 2025, was approved as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 69 asset managers below reported 20,668,022 for, 24,148 against, 1,230 abstained.

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.